Microfluidics

Why are Microfluidizer® processors preferred by top companies for their cell disruption needs? Our high-yield cell lysis technology is: * Easy to use and requires little maintenance * Fast to process compared to alternative methods * Efficient and results in high yields Microfluidics offers technologies to meet the variable and demanding needs for cell disruption, from gentle disruption of cultured mammalian cells to the challenging disruption of yeast and other fungi. To learn how Microfluidics is able to achieve superior cell disruption results, read our article: https://hubs.la/Q036CFpH0 #Microfluidizer #Microfluidics #celldisruptionproduction #celllyse #cellrupture #Microfluidizerprocessors #highshearprocessors #Microfluidizertechnology #Microfluidizerprocessor #Microfluidics #benchtopprocessor #highpressureprocessing #particlesizereduction #nanoemulsions #celldisruption #uniformparticlesizereduction #BenchtopHomogenizers

Which machine best suits your needs? Microfluidics offers a wide range of processors for various industries, applications, and volumes. However, knowing which processor is most suitable for a particular challenge can be confusing and time-consuming. The Microfluidics Product Selector Tool is an interactive tool skillfully designed to take the guesswork out of selecting a high-shear processor to suit your distinct needs. Learn more about our Product Selector Tool: https://hubs.la/Q036CP220 #highshearprocessor #homogenizer #Microfluidics #Microfluidizertechnology #MIcrofluidizerprocessor #vaccine #celldisruption #productselectortool #Microfluidizertechnology #Microfluidizerprocessor #Microfluidics #benchtopprocessor #highpressureprocessing #particlesizereduction #nanoemulsions #celldisruption #uniformparticlesizereduction #BenchtopHomogenizers

Cell disruption is a critical step in vaccine development and it’s important to select the right method. Using the correct method from the start will support your project’s viability and value through to production. Conventional methods such as bead milling, mortar and pestle, sonication, chemical lysis, and French press face drawbacks and leave product vulnerable to variable temperature and shear, protein loss through overheating or contamination, and uneven particle size distribution. In addition, many cell disruption techniques are simply not practical to transfer up from lab to production scale. How do the various methods compare and why is Microfluidizer® technology considered an industry leader in cell disruption? Read more to learn why top pharmaceutical companies trust Microfluidics for their cell disruption needs: https://hubs.la/Q036CJYV0 #celldisruption #celllyse #cellrupture #Microfluidics #Microfluidizertechnology #celldisruptionmethods #scaleuptechnology #scalabilityproduction #Microfluidizerprocessor #Microfluidics #benchtopprocessor #highpressureprocessing #particlesizereduction #nanoemulsions #celldisruption #uniformparticlesizereduction #BenchtopHomogenizers

Why is the LM10 benchtop Microfluidizer® processor such a popular choice? This lab unit, with its digital controls, is perfect for researchers who are mindful of their budget and need to process small sample materials. Microfluidizer® technology stands at the forefront of high-pressure processing, expertly transforming fluid pressure into shear forces. Its innovative approach to maintaining consistent process pressure guarantees that every bit of your material receives uniform treatment. Learn more: https://hubs.la/Q036CFSt0 #Microfluidizertechnology #Microfluidizerprocessor #Microfluidics #benchtopprocessor #highpressureprocessing #particlesizereduction #nanoemulsions #celldisruption #uniformparticlesizereduction #BenchtopHomogenizers

Very good service of our partner Instrumat in Switzerland for anyone interested in evaluating Microfluidizer technology for a specific application. Do not hesitate to contact the Instrumat team if you would also like to run some experiments!

One of the more beneficial chemotherapeutic delivery platforms is nanoparticle albumin bound (nab) paclitaxel due to its high efficiency and improved tolerability. The best and proven way to create nab-nanoparticles is through the process of emulsification. Microfluidizer® technology is a proven technology in nanoemulsion applications, which is a critical step in creating the nab paclitaxel nanoparticles which require precise particle size control. Drug delivery nanoemulsions must be sterilized and sterile filtration is a cost efficient and gentle method. Through Microfluidizer® technology, very narrow particle size nanoemulsions are created and can pass through sterilizing filters without losing product or clogging the equipment which would hinder production. Microfluidizer® processors not only produce stable emulsions but also facilitate efficient sterile filtration which comply with cGMP regulations. https://hubs.la/Q034Rb3g0 #NAB #nanoparticlealbuminboundpaclitaxel #nabpaclitaxel #nabnanoparticles #Microfluidizertechnology #nanoemulsions #Microfluidics #Microfluidizerprocessors #cGMPmanufacturingregulation #drugdeliverynanoemulsions

Why do top pharmaceutical companies turn to Microfluidics for their nanotechnology solutions? Our Microfluidizer® processors are the industry benchmark for applications demanding high shear. The combination of our constant pressure pumping system and unique fixed-geometry Interaction Chamber™ elevates our Microfluidizer® technology, empowering our clients to achieve exceptional results, with higher yields of active ingredients and enhanced control over process consistency. Discover how Microfluidics designs, develops, and constructs to the highest standards https://hubs.la/Q034R36H0 #InteractionChamber #highshearprocessors #Microfluidics #Microfluidizertechnolgoy #Microfluidizerprocessor

Lipid Nanoparticles (LNPs) are promising non-viral delivery vehicles made of specific lipids and excipients. Recently highlighted by COVID-19 vaccines from Moderna and Pfizer, LNPs have taken cetre stage as critical delivery systems of nucleic acids, especially messenger RNA (mRNA). This technology not only protects the payload but also overcomes multiple physiological barriers. Beyond rapid vaccine development, LNPs can deliver therapies for infectious diseases, immuno-oncology, genetic disorders, and neurodegenerative conditions. In this application note, we explore how Microfluidizer® technology plays a vital role in safely producing lipid nanoparticles. https://hubs.la/Q034Q_J80 #LNPs #topdownmanufacturing #lipidnanoparticles #LNPmanufacturing #vaccinemanufacturing #Microfluidics #Microfluidizertechnology #Microfluidizerprocessor

The MP350 Microlyser™ processor is an innovation in maximizing high yields in cell disruption on the production scale. Designed specifically for biotech applications and engineered with full cGMP compliance in mind, our precision-designed/manufactured machine readily achieves high-yield cell disruption results. For large volume cell disruption, the MP350 Microlyser™ processor is the answer! https://hubs.la/Q034QZmz0 Call us TODAY to learn more! #celldisruption #Microlyserprocessor #productionscalecelldisruption #Microfluidics

Join Us for the Real-Time Monitoring in Biopharma Forum! Optimal Biotech Group, alongside our industry partners, is bringing together experts to discuss cutting-edge real-time monitoring technologies in biopharma. From Raman spectroscopy to capacitance-based PAT, this free in-person event is your chance to network, gain insights, and enjoy complimentary food and drinks. 📅 Date: March 12, 2025 from 5pm-7:30pm 📍 Location: Genentech Campus, Building 35, South San Francisco Our Speakers & Session: ✅ Zhenqi (Pete) Shi, Genentech – Raman Spectroscopy-based PAT in synthetic molecule development ✅ Matt Moran, Bayer | Pharmaceuticals – Real-time stem cell growth monitoring with capacitance-based PAT ✅ Yang Su, IDEX Corporation MPT – Scalable technology for nanoparticle delivery & cell disruption 👉 Reserve your spot now: https://lnkd.in/gvdKfmjR Industry Partners: Aber Instruments Ltd Tornado - A Bruker Company Microfluidics American Association of Pharmaceutical Scientists (AAPS) | @aapscomms Bay Area Discussion Group (AAPS-BADG) #Biopharma #ProcessAnalytics #PAT #RamanSpectroscopy #Bioprocessing #LifeSciences